Leonid Mikhailovich Rapoport

Leonid Mikhailovich Rapoport

Auto-generated profile, based on publicly available information

Leonid Mikhailovich Rapoport

Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 September 2019 in World Journal of Urology
Verified
Journal Article
Closed access
PDF file
Benedikt BeckerBenedikt Becker
Benedikt Becker
DEDmitry Enikeev
Dmitry Enikeev
PGPetr Glybochko
Petr Glybochko
LRLeonid Rapoport
Leonid Rapoport
MTMark Taratkin
Mark Taratkin
CNChristopher Netsch
Christopher Netsch

9 May 2018 in Urologia Journal
Verified
Journal Article
Open access
AVAndrey Zinovievich Vinarov
Andrey Zinovievich Vinarov
LSLeonid Grigorievich Spivak
Leonid Grigorievich Spivak
DPDarina Vladimirovna Platonova
Darina Vladimirovna Platonova
LRLeonid Mikhailovich Rapoport
Leonid Mikhailovich Rapoport
DKDmitry Olegovich Korolev
Dmitry Olegovich Korolev
The aim of this study is to investigate the efficacy and safety of long-term therapy with Serenoa repens extract with regard to halting benign prostatic hyperplasia progression. An open non-comparative observational study of the continuous use of S. repens plant extract at a dosage of 320 mg once a day for 15 years was performed in 30 patients at risk for benign prostatic hyperplasia progression. Changes in IPSS (International Prostatic Symptoms Scale) and QoL (Quality of life) scores and changes in Qmax, voided volume, residual urine volume, and prostate volume were evaluated during the study. The study showed an absence of progression based on both subjective (the sum of scores on the IPSS and QoL scales) and objective (prostate volume, urination rate, residual urine volume) criteria. Furthermore, the patients had no adverse events related to the study drug, including prostate cancer. The 15 years’ study results suggest that taking S. repens plant extract continuously at a daily dose of 320 mg is an effective and safe way to prevent the progression of benign prostatic hyperplasia.

1 January 2018 in Urology Research and Practice
Verified
Journal Article
Closed access
DODaniar K. Osmonov
Daniar K. Osmonov
AFAmr A. Faddan
Amr A. Faddan
AAAlexey V. Aksenov
Alexey V. Aksenov
CNCarsten M. Naumann
Carsten M. Naumann
LRLeonid M. Rapoport
Leonid M. Rapoport
KJKlaus P. Jünemann
Klaus P. Jünemann
Objective: Surgical site infection (SSI) is defined as infection at or near surgical incisions within 30 days of an operative procedure and classified either incisional superficial and deep or organ/space. The aim of the study is to report and compare the incidence and management of SSIs after robot-assisted laparoscopic radical prostatectomy (RALP) and retropubic radical prostatectomy (RRP). Material and methods: Within the last 4 years, we identified 285 patients that underwent RRP, n=187 (66%) or RALP, n=98 (34%). We reviewed the frequency, types and way of management of SSI complications. Results: A significant difference was found between RALP and RRP (2/98, 2% vs. 27/187, 14.4%; p

30 June 2018 in Cancer Urology
Verified
Journal Article
Open access
PDF file
AVAndrey Z. Vinarov
Andrey Z. Vinarov
LRL. M. Rapoport
L. M. Rapoport
GKG. E. Krupinov
G. E. Krupinov
YDYu. L. Demidko
Yu. L. Demidko
DTD. G. Tsarichenko
D. G. Tsarichenko
VTV. A. Tereshchenko
V. A. Tereshchenko
Background. Pelvic floor muscle exercises are used as a first-line treatment for urinary incontinence after radical prostatectomy. Their efficacy is still being investigated. The use of biofeedback when teaching pelvic floor muscle exercises to patients increases the effectiveness of therapy.Objective: to assess the efficacy of biofeedback-assisted pelvic floor muscle training in patients with urinary incontinence after laparoscopic and robot-assisted radical prostatectomy and to compare the results of teaching.Materials and methods. A total of 64 patients with urinary incontinence after nerve sparing prostatectomy underwent biofeedback-assisted pelvic floor muscle rehabilitation. Radical laparoscopic surgery was performed in 48 (75 %) patients, whereas robot-assisted surgery was performed in 16 (25 %) patients. The patients started their training 2 months postoperatively. We used two-channel electromyography with the Neurotrack ETS system (United Kingdom) to teach the patients isolated pelvic floor muscle contractions. After achieving a minimum activity of abdominal muscles during pelvic floor muscle contractions, the patients started exercises.Results. There was no significant difference in age between patients who underwent laparoscopic and robot-assisted radical prostatectomy (р = 0.79). Fifty-five patients (85.9%) acquired the skill of isolated pelvic floor muscle contractions and could perform training on their own. The remaining 9 patients (14.1 %) required regular support from healthcare professionals at an outpatient unit (1–2 biofeedback-assisted trainings per month). Thus, the type of surgery did not affect the process of training. The type of radical prostatectomy had no impact on the acquisition of the pelvic floor muscle contraction skill.Conclusion. The time for restoration of urinary continence by biofeedback-assisted pelvic floor muscle training did not vary between patients after laparoscopic and robot-assisted radical prostatectomy.

26 August 2021 in Andrology and Genital Surgery
Verified
Journal Article
Open access
PDF file
EGE. N. Gasanov
E. N. Gasanov
DCD. V. Chinenov
D. V. Chinenov
GAG. N. Akopyan
G. N. Akopyan
ESE. V. Shpot’
E. V. Shpot’
MKM. A. Kodzokov
M. A. Kodzokov
LRL. M. Rapoport
L. M. Rapoport
The study objective is to improve results of treatment of patients with prostate cancer (PC) and low oncological risk. Materials and methods . Since November of 2019 at the Institute of Urology and Human Reproductive Health of the I.M. Sechenov First Moscow State Medical University 40 patients with PC and low oncological risk were included in the protocol of active observation. In all patients, the level of prostate-specific antigen was evaluated every 3 months, digital rectal examination was performed every 6 months, magnetic resonance tomography of the pelvis with intravenous contrast was performed every 12 months. Confirming biopsy of the prostate was performed once, 1 year after the beginning of observation. Every 6 months patients' quality of life was evaluated using the SF-36 (Short Form 36 Health Quality Survey), IIEF-5 (International Index of Erectile Function), IPSS (International Prostate Symptom Score), EPIC-26 (Expanded Prostate Cancer Index Composite) questionnaires. Results. Two (5 %) patients underwent surgical treatment due to PC progression. One (2.5 %) patient preferred treatment due to oncological anxiety. Mean value per the SF-36 questionnaire at the beginning of the study was 63.2 ± 11.5 for psychological component of health and 57.1 ± 9.8 for physical component of health. At the moment, the assessment of the psychological and physical components of health according to SF-36 is 69.5 ± 12.4 and 66.3 ± 8.9 points, respectively. Mean IIEF-5 value at the beginning of the study was 18.8 ± 4.2, currently it is 18.6 ± 3.9. At the beginning of the study mean IPSS value was 9.1 ± 2.1, currently it is 9.4 ± 1.9. For the EPIC-26 questionnaire mean value for all criteria initially was 56.1 ± 5.1, currently it is 68.2 ± 4.6. Conclusion . First results of active observation of patients with PC and low oncological risk demonstrated that this approach allows to avoid unnecessary treatment of patients who do not require immediate intervention and to start treatment on time in cases where it is required while preserving high quality of life for the patients.

9 January 2023 in Andrology and Genital Surgery
Verified
Journal Article
Open access
PDF file
RKRoman Komarov
Roman Komarov
LRL. M. Rapoport
L. M. Rapoport
OOO. O. Ognev
O. O. Ognev
AIA. M. Ismailbayev
A. M. Ismailbayev
BTB. M. Tlisov
B. M. Tlisov
КРК. Ю. Рябов
К. Ю. Рябов
Renal cell carcinoma with inferior vena cava (IVC) thrombosis is a rare disease with a poor prognosis without surgical treatment. The presence of a tumor thrombus in the cavity of the main vessel in most cases is accompanied by massive bleeding during thrombectomy. To reduce the volume of blood loss, it is possible to use cardiopulmonary bypassto reduce the potential risks associated with blood loss and unstable hemodynamics. Sometimes tumor thrombosis can be growth into the vein wall or lead to occlusion IVC, we consider that it’s indication for resection of the IVC. Thrombectomy with laparotomy access can be performed even with type IV tumor thrombosis, if the thrombus is not fixed to the wall of the suprarenal IVC and surgeon have enough view of suprarenal segment. This article presents a variant of surgical treatment of patients with right kidney cancer, type IV IVC thrombosis, occlusion infrarenal IVC and ileofemoral thrombosis. In both cases we made resection IVC – infrarenal segment in first case and suprarenal segment in second case.